Evaluating a suite of anti-FAP nanobody constructs as PET imaging agents.Joseph Gallant1, Zackary Rosenkrans2, Kendahl Ott1, Natalie Luo1, Anna Thickens2, Reinier Hernandez2, and Aaron LeBeau1
|
Novel PD-L1- and collagen-expressing patient-derived cell line of undifferentiated pleomorphic sarcoma as a model for cancer immunotherapyPavla Taborska1, Pavol Lukac4,8, Dmitry Stakheev1,4, Lenka Rajsiglova4,8, Karolina Strnadova2,3, Lukas Lacina2,3,9, Barbora Dvorankova2,3, Jiri Novotny5, Michal Kolar5, Milena Vrana6, Hana Cechova6, Sarka Ransdorfova7, Marie Valerianova7, Karel Smetana2,3, Luca Vannucci4, and Daniel Smrz1,4
|
Stress conditions within tumour microenvironment rewire Receptor Tyrosine Kinases signallingChiara Francavilla1, Jennifer Ferguson2, Jess Price2, and Michael Smith2
|
Metabolomics and lipidomics reveal metabolic phenotype in tamoxifen-resistant breast carcinoma cell lines Klára Gotvaldová1, Jitka Špačková1, Jaroslav Truksa2, Petr Ježek1, and Katarína Smolková 1
|
Bioenergetics and metabolic reprogramming of mesenchymal stromal cells and their use for applications in regenerative medicineJitka Špačková1, Klára Gotvaldová1, Jarmila Havelková2,4, Elena Rogulska2,4, Eliška Vavřinová2, Katarína Smolková1, Yuriy Petrenko2,4, and Petr Ježek1
|
CD47 regulates cellular and metabolic plasticity in glioblastomaRuhi Polara, Raja Ganesan, and Nirmal Robinson
|
Metabolic interplay of both cyclooxygenase-2 (COX-2) and macrophages/microglia during U87 glioblastoma tumor growthCathleen Haase-Kohn1, Magali Toussaint4, Sebastian Meister1, Cornelius Donat2, Markus Laube1, Frank Hofheinz3, Winnie Deuther-Conrad4, and Jens Pietzsch1,5
|
Comparative evaluation of exosomal microRNA isolation methods from cerebrospinal fluid for their subsequent profiling in glioma patientsMichaela Ruckova1,2, Dagmar Al Tukmachi1,2, Marek Vecera1,2, Michal Hendrych4, Marketa Hermanova4, Vaclav Vybihal3, Pavel Fadrus3, Martina Hyzdalova5, Katerina Pencikova5, Jan Kotoucek5, Nicol Strakova5, Pavel Kulich5, and Jiri Sana1
|
The Role of the Unfolded Protein Response in mechanisms of Treatment Resistance in Prostate CancerDimitrios Doultsinos
|
Role of Iron in Metastatic SpreadKonstantin Salnikow
|
Epigenetic targeting of cholesterol biosynthesis eliminates chemotherapy-tolerant persister cells in glioblastomaGeorge Joun1, Brianna Chen1, Hani Kim2, Pengyi Yang2, Anthony Don1, and Lenka Munoz1
|
GCN2 in and out of stressVilte Stonyte1, Maria Mastrangelopoulou1, Romy Timmer2, Marina Vietri3, Heidi Lyng1, Coen Campsteijn2, and Beata Grallert1
|
Hypoxia shapes the chromatin accessibility changes in glioma-reprogrammed microglial cellsMonika Dzwigonska1, Jakub Mieczkowski2, Bożena Kaminska1, and Katarzyna Leszczynska1
|
Cell Communication in the Microenvironment of Vestibular SchwannomaJana Sachova1, Miluse Hradilova3, Michaela Tesarova4, Lenka Peterkova4, Monika Stastna2, Lucie Pfeiferová1, Sarka Kocourkova1, Martina Krausova1, Marcela Vedralova1, Michal Kolar1, Zdenek Fik4, and Jan Plzak4
|
Understanding the role of Mitochondria in Cancer and Age Marcia Haigis
|
Metabolic alterations in tumor and host in cancerEileen White
|
Bad and Good Consequences of Targeted Removal of Senescent Cancer-Associated Fibroblasts (CAFs) and Tumor-Associated Macrophages (TAMs) in the Tumor MicroenvironmentDaria Bogdanova1,2, Lisa Lagorgette 3, Tomara Pukhalskaya1,2, Carmen Garrido3, and Oleg Demidov1,2,3
|
Breast microbiota influences the tumor microenvironment to modulate mammary carcinogenesis riskKatherine Cook, Kenysha Clear, Adam Wilson, Neil Iyengar, and David Soto-Pantoja
|
Towards functional precision medicine in glioblastoma research- Paving the way with biobanking and cancer neuroscienceMaria Tsiarli1, Constantinos Zamboglou2,4, Marilena Theodorou3, and Constantinos Deltas1
|
Modeling and Comparative Analysis of FLASH Radiotherapy for Head and Neck Cancer and Lung Cancer: Proton Therapy and Heavy Particle Beams
Erato Stylianou Markidou1, Constantinos Koumenis2, Amir Abdullahi3, and Andrea Mairani4
|
Adaptive resistance to estrogen receptor inhibition is overcome by targeting MCL-1 Konstantinos Floros1, Sheeba Jacob1, Bin Hu2, Madhavi Puchalapalli2, Mohammad Alzubi2, Richard Kurupi3, Sosipatros Boikos4, Sarat Chandarlapaty5, Jennifer Koblinski2, Joshua Harrell6, Maurizio Scaltriti7, and Anthony Faber1
|
Potential of Chimeric IL-15 in Treatment and Prevention of CancerPriya Sharma, Digna Patel, and Sarat Dalai
|
TarBase-v9.0 extends experimentally supported miRNA-gene interactions to cell-types and virally-encoded miRNAsGiorgos Skoufos1,2, Artemis Hatzigeorgiou1,2, Spyros Tastsoglou1,2, Panos Kakoulidis3, Maria Zioga1, and Angeliki Velli1
|
Tumor-intrinsic LKB1-LIF signaling axis establishes a myeloid niche to promote immune evasion and Sox17-mediated lineage plasticityAli Rashidfarrokhi1,2, Ray Pillai1,3,4, Mariana Mancini1, Yuan Hao5,6, Warren Wu1,2, Burcu Karadel-Ferrena1, Sofia Dimitriadoy1, Michael Cross1,2, Anna Yeaton1,6, Shih Ming Huang1, Arjun Bhutkar7, Alberto Herrera1, Sahith Rajalingam1, Makiko Hayashi1, Kuan-lin Huang8, Eric Bartnicki2,9, Anastasia Zavitsanou 1,2, Corrin Wohlhieter10, Sarah Leboeuf1, Ting Chen11, Cynthia Loomis12, Valeria Mezzano12, Ruth Kulicke13, Fred Davis13, Nicolas Stransky13, Gromoslaw Smolen13, Charles Rudin12,14, Andre Moreira1, Kamal Khanna6,9, Harvey Pass15, Kwok-Kin Wong11, Shohei Koide6,16, Aristotelis Tsirigos6, Sergei Koralov1,6, and Thales Papagiannakopoulos1,6
|
DIANA-miRPath v4.0: Context-specific analysis of combined miRNA functions Artemis Hatzigeogriou
|
MicroRNAs profiling and their interconnected transcription factors regulators in NSCLC
Ekaterina Isachesku1, Lajos Raduly1, Oana Zanoaga1, Antonia Harangus2, Marioara Simon2, Ovidiu Pop3, Cecilia Bica1, and Ioana Berindan-Neagoe1
|
